The global Memantine Market is estimated to be valued at US$ 565.93 Bn in 2022 and is expected to exhibit a CAGR of 3.87% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.Market Overview: Memantine is a prescription drug used for the treatment of moderate to severe Alzheimer's disease. It belongs to a class of drugs called NMDA receptor...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian